DE60204452D1 - Pyrazolo[1,5]pyridinderivate - Google Patents
Pyrazolo[1,5]pyridinderivateInfo
- Publication number
- DE60204452D1 DE60204452D1 DE60204452T DE60204452T DE60204452D1 DE 60204452 D1 DE60204452 D1 DE 60204452D1 DE 60204452 T DE60204452 T DE 60204452T DE 60204452 T DE60204452 T DE 60204452T DE 60204452 D1 DE60204452 D1 DE 60204452D1
- Authority
- DE
- Germany
- Prior art keywords
- pyridine derivatives
- same
- variables
- preparing
- processes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28694801P | 2001-04-27 | 2001-04-27 | |
US286948P | 2001-04-27 | ||
PCT/US2002/010687 WO2002088124A2 (en) | 2001-04-27 | 2002-04-05 | Pyrazolo'1,5-a!pyridine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60204452D1 true DE60204452D1 (de) | 2005-07-07 |
DE60204452T2 DE60204452T2 (de) | 2005-12-15 |
Family
ID=23100830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60204452T Expired - Fee Related DE60204452T2 (de) | 2001-04-27 | 2002-04-05 | Pyrazolo[1,5a]Pyridinderivate |
Country Status (8)
Country | Link |
---|---|
US (3) | US6962914B2 (de) |
EP (1) | EP1385847B1 (de) |
JP (1) | JP2004527560A (de) |
AT (1) | ATE296826T1 (de) |
AU (1) | AU2002305143A1 (de) |
DE (1) | DE60204452T2 (de) |
ES (1) | ES2242028T3 (de) |
WO (1) | WO2002088124A2 (de) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20020506A1 (es) * | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
JP2004515550A (ja) * | 2000-12-15 | 2004-05-27 | グラクソ グループ リミテッド | 治療用化合物 |
JP2004529119A (ja) * | 2001-03-08 | 2004-09-24 | スミスクライン ビーチャム コーポレーション | ピラゾロピリジン誘導体 |
ATE332301T1 (de) * | 2001-04-10 | 2006-07-15 | Smithkline Beecham Corp | Antivirale pyrazolopyridin verbindungen |
US20040214834A1 (en) * | 2001-09-07 | 2004-10-28 | Kristjan Gudmunsson | Pyrazolo-pyridines for the treatment of herpes infections |
EP1453830B1 (de) * | 2001-12-11 | 2007-09-12 | SmithKline Beecham Corporation | Pyrazolopyridin-derivate als antiherpesmittel |
AU2003217712A1 (en) | 2002-03-07 | 2003-09-22 | Smithkline Beecham Corporation | Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them |
WO2006055245A2 (en) * | 2004-11-17 | 2006-05-26 | Smithkline Beecham Corporation | Process for preparing pyrazolopyridine compounds |
US7812022B2 (en) * | 2004-12-21 | 2010-10-12 | Glaxosmithkline Llc | 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors |
US7807673B2 (en) * | 2005-12-05 | 2010-10-05 | Glaxosmithkline Llc | 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors |
UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
EP2845856A1 (de) | 2009-06-29 | 2015-03-11 | Incyte Corporation | Pyrimidone als PI3K-Hemmer |
US8680108B2 (en) * | 2009-12-18 | 2014-03-25 | Incyte Corporation | Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors |
WO2011075643A1 (en) | 2009-12-18 | 2011-06-23 | Incyte Corporation | Substituted heteroaryl fused derivatives as pi3k inhibitors |
AR081810A1 (es) | 2010-04-07 | 2012-10-24 | Bayer Cropscience Ag | Piridinilpirazoles biciclicos |
AR081823A1 (es) | 2010-04-14 | 2012-10-24 | Incyte Corp | DERIVADOS FUSIONADOS COMO INHIBIDORES DE PI3Kd |
US9062055B2 (en) | 2010-06-21 | 2015-06-23 | Incyte Corporation | Fused pyrrole derivatives as PI3K inhibitors |
EP2402336A1 (de) | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazolopyridin-Verbindungen |
EP2402335A1 (de) | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazolopyridin-Verbindungen |
US9096600B2 (en) | 2010-12-20 | 2015-08-04 | Incyte Corporation | N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors |
EP2667874A4 (de) * | 2011-01-27 | 2014-07-30 | Univ Princeton | Mtor-kinase-hemmer als antivirusmittel |
US9108984B2 (en) | 2011-03-14 | 2015-08-18 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors |
US9126948B2 (en) | 2011-03-25 | 2015-09-08 | Incyte Holdings Corporation | Pyrimidine-4,6-diamine derivatives as PI3K inhibitors |
BR112014004971B1 (pt) | 2011-09-02 | 2021-02-09 | Incyte Holdings Corporation | compostos heterociclilaminas, sua composição farmacêutica e seus usos |
AR090548A1 (es) | 2012-04-02 | 2014-11-19 | Incyte Corp | Azaheterociclobencilaminas biciclicas como inhibidores de pi3k |
WO2015191677A1 (en) | 2014-06-11 | 2015-12-17 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors |
KR102431436B1 (ko) | 2014-08-29 | 2022-08-10 | 테스 파마 에스.알.엘. | α-아미노-β-카복시뮤콘산 세미알데히드 데카복실라제의 억제제 |
SI3831833T1 (sl) | 2015-02-27 | 2023-03-31 | Incyte Holdings Corporation | Postopki za pripravo inhibitorja PI3K |
WO2016183063A1 (en) | 2015-05-11 | 2016-11-17 | Incyte Corporation | Crystalline forms of a pi3k inhibitor |
WO2016183060A1 (en) | 2015-05-11 | 2016-11-17 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
ES2928164T3 (es) | 2015-10-19 | 2022-11-15 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
MX2018006207A (es) | 2015-11-19 | 2018-09-05 | Incyte Corp | Compuestos heterociclicos como inmunomoduladores. |
EA201891494A1 (ru) | 2015-12-22 | 2019-01-31 | Инсайт Корпорейшн | Гетероциклические соединения в качестве иммуномодуляторов |
EP3452476B1 (de) | 2016-05-06 | 2021-12-15 | Incyte Corporation | Heterocyclische verbindungen als immunmodulatoren |
ES2905980T3 (es) | 2016-05-26 | 2022-04-12 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
HUE060256T2 (hu) | 2016-06-20 | 2023-02-28 | Incyte Corp | Heterociklusos vegyületek mint immunmodulátorok |
US20180016260A1 (en) | 2016-07-14 | 2018-01-18 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
WO2018044783A1 (en) | 2016-08-29 | 2018-03-08 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
EP3558973B1 (de) | 2016-12-22 | 2021-09-15 | Incyte Corporation | Pyridinderivate als immunmodulatoren |
WO2018119236A1 (en) | 2016-12-22 | 2018-06-28 | Incyte Corporation | Triazolo[1,5-a]pyridine derivatives as immunomodulators |
HRP20221216T1 (hr) | 2016-12-22 | 2022-12-23 | Incyte Corporation | Derivati tetrahidro imidazo[4,5-c]piridina kao induktori internalizacije pd-l1 |
KR20190111025A (ko) | 2016-12-22 | 2019-10-01 | 인사이트 코포레이션 | 면역조절제로서의 벤조옥사졸 유도체 |
HRP20230090T1 (hr) | 2018-03-30 | 2023-03-17 | Incyte Corporation | Heterociklički spojevi kao imunomodulatori |
SG11202011165TA (en) | 2018-05-11 | 2020-12-30 | Incyte Corp | Tetrahydro-imidazo[4,5-c]pyridine derivatives as pd-l1 immunomodulators |
MX2022001671A (es) | 2019-08-09 | 2022-05-13 | Incyte Corp | Sales de un inhibidor de pd-1/pd-l1. |
EP4037773A1 (de) | 2019-09-30 | 2022-08-10 | Incyte Corporation | Pyrido[3,2-d]pyrimidin-verbindungen als immunmodulatoren |
AU2020385113A1 (en) | 2019-11-11 | 2022-05-19 | Incyte Corporation | Salts and crystalline forms of a PD-1/PD-L1 inhibitor |
US11760756B2 (en) | 2020-11-06 | 2023-09-19 | Incyte Corporation | Crystalline form of a PD-1/PD-L1 inhibitor |
JP2023548859A (ja) | 2020-11-06 | 2023-11-21 | インサイト・コーポレイション | Pd-1/pd-l1阻害剤ならびにその塩及び結晶形態を作製するためのプロセス |
WO2022099018A1 (en) | 2020-11-06 | 2022-05-12 | Incyte Corporation | Process of preparing a pd-1/pd-l1 inhibitor |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0151962A3 (de) * | 1984-01-25 | 1985-10-02 | Beecham Group Plc | Pyrazolopyridin-Derivate |
GB8404586D0 (en) * | 1984-02-22 | 1984-03-28 | Beecham Group Plc | Compounds |
GB8404584D0 (en) * | 1984-02-22 | 1984-03-28 | Beecham Group Plc | Compounds |
US5002941A (en) | 1985-12-12 | 1991-03-26 | Smithkline Beecham Corporation | Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors |
US4925849A (en) * | 1987-06-15 | 1990-05-15 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutically useful pyrazolopyridines |
US5155114A (en) * | 1989-01-23 | 1992-10-13 | Fujisawa Pharmaceutical Company, Ltd. | Method of treatment using pyrazolopyridine compound |
GB8901423D0 (en) * | 1989-01-23 | 1989-03-15 | Fujisawa Pharmaceutical Co | Pyrazolopyridine compound and processes for preparation thereof |
CA2060309A1 (en) | 1989-06-13 | 1990-12-14 | Alison M. Badger | Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages |
AU622330B2 (en) * | 1989-06-23 | 1992-04-02 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides |
CA2084290A1 (en) | 1990-06-12 | 1991-12-13 | Jerry L. Adams | Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases |
GB9015764D0 (en) | 1990-07-18 | 1990-09-05 | Fujisawa Pharmaceutical Co | Pyrazolopyridine compound and processes for preparation thereof |
EP0497258B1 (de) | 1991-01-29 | 2002-01-02 | Fujisawa Pharmaceutical Co., Ltd. | Verwendung von Adenosinantagonisten zur Vorbeugung und Behandlung von Pankreatitis und Ulcera |
GB9107513D0 (en) * | 1991-04-10 | 1991-05-29 | Fujisawa Pharmaceutical Co | Pyrazolopyridine compound and processes for preparation thereof |
US5300478A (en) * | 1993-01-28 | 1994-04-05 | Zeneca Limited | Substituted fused pyrazolo compounds |
US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
US5497774A (en) * | 1993-11-03 | 1996-03-12 | Daig Corporation | Guiding introducer for left atrium |
JP3572617B2 (ja) * | 1993-12-29 | 2004-10-06 | 藤沢薬品工業株式会社 | ピラゾロピリジンアデノシン拮抗剤 |
US5521213A (en) | 1994-08-29 | 1996-05-28 | Merck Frosst Canada, Inc. | Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
US5552422A (en) | 1995-01-11 | 1996-09-03 | Merck Frosst Canada, Inc. | Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents |
HUP9801602A3 (en) | 1995-04-04 | 1999-01-28 | Glaxo Group Ltd | Imidazo[1,2-a]pyridine derivatives, process for their production, pharmaceutical compositions and use thereof |
US5700816A (en) | 1995-06-12 | 1997-12-23 | Isakson; Peter C. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor |
AU6269496A (en) | 1995-06-12 | 1997-01-09 | G.D. Searle & Co. | Combination of a cyclooxygenase-2 inhibitor and a leukotrien e b4 receptor antagonist for the treatment of infla mmations |
ATE301457T1 (de) * | 1995-06-12 | 2005-08-15 | Searle & Co | Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor |
US5670432A (en) | 1996-08-01 | 1997-09-23 | Taiwan Semiconductor Manufacturing Company, Ltd. | Thermal treatment to form a void free aluminum metal layer for a semiconductor device |
FR2757166B1 (fr) * | 1996-12-12 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent |
FR2757059B1 (fr) | 1996-12-12 | 1999-01-29 | Rhone Poulenc Rorer Sa | Nouvelle application therapeutique des derives du pyrrole |
JP2002504909A (ja) | 1997-06-13 | 2002-02-12 | スミスクライン・ビーチャム・コーポレイション | 新規な置換ピラゾールおよびピラゾリン化合物 |
DE69833464T2 (de) | 1997-09-05 | 2006-08-24 | Glaxo Group Ltd., Greenford | Pharmazeutische Zusammensetzung, enthaltend 2,3-Diaryl-PyrazoloÄ1,5-bÜPyridazin Derivate |
JP2002514640A (ja) | 1998-05-14 | 2002-05-21 | ジー・ディー・サール・アンド・カンパニー | p38キナーゼ阻害剤としての1,5−ジアリール置換ピラゾール類 |
US6245789B1 (en) | 1998-05-19 | 2001-06-12 | The Procter & Gamble Company | HIV and viral treatment |
FR2779724B1 (fr) * | 1998-06-10 | 2001-04-20 | Rhone Poulenc Rorer Sa | Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent |
BR9915011A (pt) | 1998-11-03 | 2001-08-07 | Glaxo Group Ltd | Compostos, método para a preparação dos mesmos, composição farmacêutica, métodos de tratamento de um indivìduo humano ou animal sofrendo de uma condição que é mediada pela inibição seletiva de cox-2 e sofrendo de um distúrbio inflamatório, e, uso de um composto |
AU2661400A (en) | 1999-02-27 | 2000-09-21 | Glaxo Group Limited | Pyrazolopyridines |
ES2215670T3 (es) | 1999-06-28 | 2004-10-16 | Janssen Pharmaceutica N.V. | Inhibidores de la replicacion del virus sincitial respiratorio. |
GB9919778D0 (en) | 1999-08-21 | 1999-10-27 | Zeneca Ltd | Chemical compounds |
US7075927B2 (en) * | 2000-05-05 | 2006-07-11 | Fujitsu Limited | Method and system for quality of service (QoS) support in a packet-switched network |
PE20020506A1 (es) | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
AUPQ969800A0 (en) | 2000-08-28 | 2000-09-21 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyridine compound and pharmaceutical use thereof |
US20020114274A1 (en) * | 2000-09-19 | 2002-08-22 | Sturges James H. | Packet based network for supporting real time applications |
JP2004515550A (ja) | 2000-12-15 | 2004-05-27 | グラクソ グループ リミテッド | 治療用化合物 |
JP2004518651A (ja) | 2000-12-15 | 2004-06-24 | グラクソ グループ リミテッド | 治療用化合物 |
GB0103926D0 (en) | 2001-02-17 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
US7196095B2 (en) | 2001-06-25 | 2007-03-27 | Merck & Co., Inc. | (Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds |
US7042841B2 (en) * | 2001-07-16 | 2006-05-09 | International Business Machines Corporation | Controlling network congestion using a biased packet discard policy for congestion control and encoded session packets: methods, systems, and program products |
US6711762B2 (en) | 2002-01-30 | 2004-03-30 | Ktk Services, Inc. | Method of using a truck cab bridge bed |
US7701934B2 (en) * | 2004-11-02 | 2010-04-20 | At&T Intellectual Property I, L.P. | System and method for managing devices within a private network via a public network |
US20060092833A1 (en) * | 2004-11-02 | 2006-05-04 | Bemmel Jeroen V | Congestion control for improved management of service level agreements in switched networks |
-
2002
- 2002-04-05 JP JP2002585423A patent/JP2004527560A/ja active Pending
- 2002-04-05 US US10/473,751 patent/US6962914B2/en not_active Expired - Fee Related
- 2002-04-05 EP EP02733945A patent/EP1385847B1/de not_active Expired - Lifetime
- 2002-04-05 ES ES02733945T patent/ES2242028T3/es not_active Expired - Lifetime
- 2002-04-05 AT AT02733945T patent/ATE296826T1/de not_active IP Right Cessation
- 2002-04-05 AU AU2002305143A patent/AU2002305143A1/en not_active Abandoned
- 2002-04-05 WO PCT/US2002/010687 patent/WO2002088124A2/en active IP Right Grant
- 2002-04-05 DE DE60204452T patent/DE60204452T2/de not_active Expired - Fee Related
-
2005
- 2005-03-31 US US11/095,361 patent/US20050192295A1/en not_active Abandoned
- 2005-03-31 US US11/095,212 patent/US7030134B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2002088124A3 (en) | 2003-05-08 |
ATE296826T1 (de) | 2005-06-15 |
US20040142941A1 (en) | 2004-07-22 |
US6962914B2 (en) | 2005-11-08 |
US7030134B2 (en) | 2006-04-18 |
EP1385847A2 (de) | 2004-02-04 |
WO2002088124A2 (en) | 2002-11-07 |
ES2242028T3 (es) | 2005-11-01 |
DE60204452T2 (de) | 2005-12-15 |
JP2004527560A (ja) | 2004-09-09 |
AU2002305143A1 (en) | 2002-11-11 |
US20050192295A1 (en) | 2005-09-01 |
EP1385847B1 (de) | 2005-06-01 |
US20050192303A1 (en) | 2005-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60204452D1 (de) | Pyrazolo[1,5]pyridinderivate | |
AU2002239344A1 (en) | Pyrazolopyridines | |
DE602004021472D1 (en) | Pyrimiidinverbindungen | |
ATE300541T1 (de) | Pyrazolopyridinderivate | |
ATE337316T1 (de) | Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen | |
AU2003228770A8 (en) | Substituted pyrazolopyrimidines | |
IS6658A (is) | Ný efnasambönd | |
ATE332301T1 (de) | Antivirale pyrazolopyridin verbindungen | |
DK1200418T3 (da) | Nematodicide trifluorbutener | |
DE60220525D1 (de) | Pyrazolo-pyridine für die behandlung von herpes-ansteckungen | |
AU2003217712A1 (en) | Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them | |
SE9804212D0 (sv) | Compounds | |
MXPA04001773A (es) | Derivados de 6,7-dihidroxitetrahidroisquinolinas 3-sustituidas parta uso como agentes antibacterianos. | |
ATE274515T1 (de) | Pyrazolopyridinderivate | |
SE9802574D0 (sv) | Novel compounds | |
DE60222465D1 (de) | Pyrazolopyridin-derivate als antiherpesmittel | |
SE9904128D0 (sv) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |